01.06.25 -- Trends In Proposed Laws Aimed At Drug Patents

Community-based clinical trials enhance diversity, addressing mistrust and access barriers by fostering local partnerships, and accessible trial sites for underrepresented communities.

Industry leaders gathered at the PDA Ireland Chapter event to discuss how innovation and technology are transforming biopharmaceutical manufacturing, addressing challenges, and driving efficiency.

Explore the updated guidance from the FDA to enhance diversity in clinical trials, including ten times to developing a comprehensive Diversity Action Plans.

The shift from startup to commercialization demands robust, scalable technology solutions such as ERP systems, which integrate essential functions into a single platform.

Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.